These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 3821989

  • 21. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects].
    Kornhuber HH, Mauch E.
    Dtsch Med Wochenschr; 1986 Nov 14; 111(46):1778. PubMed ID: 3780443
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of idiopathic pulmonary fibrosis].
    Dury S.
    Rev Mal Respir; 2006 Apr 14; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
    [No Abstract] [Full Text] [Related]

  • 23. [Immunodepressors in ophthalmology].
    Bonnet M.
    Annee Ther Clin Ophtalmol; 1971 Apr 14; 22():117-55. PubMed ID: 4356770
    [No Abstract] [Full Text] [Related]

  • 24. Treatment and prevention of myelin disorders: multiple sclerosis.
    Abramsky O.
    Bull Soc Belge Ophtalmol; 1983 Nov 14; 208 Pt 1():489-92. PubMed ID: 6326915
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Modern therapeutic viewpoints in the treatment of multiple sclerosis].
    Neumayer E.
    Wien Med Wochenschr; 1969 Apr 12; 119(15):281-4. PubMed ID: 5769603
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Immunodepressive therapy in bronchial asthma].
    Khanina SB, Chudinovskikh AIa, Kulenko EM.
    Ter Arkh; 1971 May 12; 43(5):100-3. PubMed ID: 5117920
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D.
    Recenti Prog Med; 1999 Oct 12; 90(10):538-44. PubMed ID: 10592740
    [Abstract] [Full Text] [Related]

  • 34. The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review.
    Goodin DS.
    Neurology; 1991 Jul 12; 41(7):980-5. PubMed ID: 2067661
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Indications for immunosuppressive agents in glomerular nephropathies].
    Méry JP, Girard JF.
    Ann Med Interne (Paris); 1974 Nov 12; 125(11):795-802. PubMed ID: 4460826
    [No Abstract] [Full Text] [Related]

  • 38. [Suspected multiple sclerosis].
    Pellkofer H, Hohlfeld R.
    MMW Fortschr Med; 2006 Mar 30; 148(13):63-4. PubMed ID: 16642711
    [No Abstract] [Full Text] [Related]

  • 39. Drug treatment of connective tissue disease.
    Hazleman BL.
    Trans Ophthalmol Soc U K (1962); 1974 Sep 30; 94(3):830-43. PubMed ID: 4534025
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.